| Natera, Inc. Common Stock | $32.0b | $267.18 | +1.6% | 530.4K | |
| Illumina Inc | $24.7b | $176.80 | -0.1% | 383.6K | |
| Labcorp Holdings Inc. | $21.3b | $268.06 | +0.7% | 78.5K | |
| QIAGEN N.V. | $7.5b | $39.03 | +0.4% | 657.7K | |
| BillionToOne, Inc. Class A Common Stock | $4.6b | $114.28 | +2.2% | 310.4K | |
| Veracyte, Inc. | $3.7b | $59.88 | +1.9% | 219.0K | |
| 10x Genomics, Inc. Class A Common Stock | $3.6b | $35.97 | +0.9% | 364.2K | |
| GeneDx Holdings Corp. Class A Common Stock | $1.5b | $69.98 | +1.0% | 172.9K | |
| NeoGenomics, Inc. | $1.4b | $13.69 | -0.5% | 359.6K | |
| Personalis, Inc. Common Stock | $1.2b | $13.10 | +3.6% | 1.6M | |
| CareDx, Inc. | $1.2b | $28.49 | +2.6% | 184.0K | |
| Opko Health Inc. | $1.1b | $1.56 | +4.3% | 1.6M | |
| Azenta, Inc. | $1.1b | $24.89 | +1.4% | 68.6K | |
| Mesa Laboratories Inc | $0.6b | $100.47 | +3.5% | 51.7K | |
| Fulgent Genetics, Inc. Common Stock | $0.5b | $19.55 | +1.0% | 29.3K | |
| Pacific Biosciences of California, Inc. | $462.8m | $1.66 | +4.4% | 3.0M | |
| Myriad Genetics Inc | $375.0m | $5.53 | +2.9% | 337.0K | |
| Prenetics Global Limited Class A Ordinary Share | $358.7m | $19.29 | -0.7% | 20.8K | |
| Insight Molecular Diagnostics Inc. Common Stock | $200.5m | $5.62 | +2.0% | 14.5K | |
| ALPS Group Inc Ordinary Share | $126.4m | $0.62 | 0.0% | 46.6K | |
| Quantum Cyber N.V. Ordinary Shares | $58.3m | $1.76 | +24.1% | 53.7M | |
| Bionano Genomics, Inc. Common Stock | $14.2m | $1.14 | +1.8% | 121.4K | |
| BioNexus Gene Lab Corp Common stock | $5.6m | $2.08 | 0.0% | 330 |